Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Renato Alberto Finazzi"'
Autor:
Adriano LAZZARIN, MASSIMO GALLI, Wendy Bannister, Emília Valadas, Robert Flisiak, Francisco Antunes, Renato Alberto Finazzi, Jens Lundgren, Dalibor Sedlacek, LUZ MARTÍN CARBONERO, Clifford Leen, Vicente Soriano, Luis Menendez Arias, Linos Vandekerckhove, Matti Ristola, Lars Østergaard, Đorđe Jevtović, Justyna Kowalska, Thomas Benfield, Viktar M. Mitsura, Terese L Katzenstein, Gilberto Betancor Quintana, Vassilenko Anna, Maria C. Puertas, Miriam Lichtner, Javier Martinez-Picado
Publikováno v:
Journal of Infectious Diseases; Vol 204
Paredes, R, Puertas, M C, Bannister, W, Kisic, M, Cozzi-Lepri, A, Pou, C, Bellido, R, Betancor, G, Bogner, J, Gargalianos, P, Bánhegyi, D, Clotet, B, Lundgren, J, Menéndez-Arias, L, Martinez-Picado, J, EuroSIDA Study Group & Pedersen, C 2011, ' A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy ', Journal of Infectious Diseases, vol. 204, no. 5, pp. 741-52 . https://doi.org/10.1093/infdis/jir385
Journal of infectious diseases, 204(5), 741-752. Oxford University Press
Paredes, R, Puertas, M C, Bannister, W, Kisic, M, Cozzi-Lepri, A, Pou, C, Bellido, R, Betancor, G, Bogner, J, Gargalianos, P, Bánhegyi, D, Clotet, B, Lundgren, J, Menéndez-Arias, L, Martinez-Picado, J & EuroSIDA Study Group (Lars Østergaard, member) 2011, ' A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy ', Journal of Infectious Diseases, vol. 204, no. 5, pp. 741-52 . https://doi.org/10.1093/infdis/jir385
JOURNAL OF INFECTIOUS DISEASES
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Paredes, R, Puertas, M C, Bannister, W, Kisic, M, Cozzi-Lepri, A, Pou, C, Bellido, R, Betancor, G, Bogner, J, Gargalianos, P, Bánhegyi, D, Clotet, B, Lundgren, J, Menéndez-Arias, L, Martinez-Picado, J, EuroSIDA Study Group & Pedersen, C 2011, ' A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy ', Journal of Infectious Diseases, vol. 204, no. 5, pp. 741-52 . https://doi.org/10.1093/infdis/jir385
Journal of infectious diseases, 204(5), 741-752. Oxford University Press
Paredes, R, Puertas, M C, Bannister, W, Kisic, M, Cozzi-Lepri, A, Pou, C, Bellido, R, Betancor, G, Bogner, J, Gargalianos, P, Bánhegyi, D, Clotet, B, Lundgren, J, Menéndez-Arias, L, Martinez-Picado, J & EuroSIDA Study Group (Lars Østergaard, member) 2011, ' A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy ', Journal of Infectious Diseases, vol. 204, no. 5, pp. 741-52 . https://doi.org/10.1093/infdis/jir385
JOURNAL OF INFECTIOUS DISEASES
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
BACKGROUND: The clinical relevance of mutations in the connection subdomain and the ribonuclease (RNase) H domain of HIV-1 reverse transcriptase (RT) is uncertain.METHODS: The risk of virological failure to nonnucleoside RT inhibitor (NNRTI)-based an
Autor:
Nina Friis-Moller, Renato Alberto Finazzi, Jens Lundgren, Dalibor Sedlacek, Antonio Chiesi, Clifford Leen, Vicente Soriano, Milosz Parczewski, Linos Vandekerckhove, Matti Ristola, Lars Østergaard, Terese L Katzenstein
Publikováno v:
HIV Medicine. 12:259-268
OBJECTIVES The durability of combination antiretroviral therapy (cART) regimens can be measured as time to discontinuation because of toxicity or treatment failure, development of clinical disease or serious long-term adverse events. The aim of this
Autor:
Ferran Torres, Nina Friis-Moller, Roberto CAUDA, Renato Alberto Finazzi, Jens Lundgren, Antonio Chiesi, Clifford Leen, Giuseppe Ippolito, CARLO FEDERICO PERNO, Vicente Soriano, Linos Vandekerckhove, Matti Ristola, Lars Østergaard, Caroline Sabin, Terese L Katzenstein, GUIDO CAMANNI, Bart Rijnders, ANDREA COSTANTINI
Publikováno v:
Worm, S W, Friis-Møller, N, Bruyand, M, D'Arminio Monforte, A, Rickenbach, M, Reiss, P, El-Sadr, W, Phillips, A, Lundgren, J, Sabin, C & D:A:D study group (Lars Østergaard, member) 2010, ' High prevalence of the metabolic syndrome in HIV-infected patients : impact of different definitions of the metabolic syndrome ', AIDS, vol. 24, no. 3, pp. 427-35 . https://doi.org/10.1097/QAD.0b013e328334344e
AIDS, 24(3), 427-435
Aids, 24, 427-35
Aids, 24(3), 427-35. LIPPINCOTT WILLIAMS & WILKINS
AIDS (London, England), 24(3), 427-435. Lippincott Williams and Wilkins
Aids, 24, 3, pp. 427-35
AIDS, 24(3), 427-435
Aids, 24, 427-35
Aids, 24(3), 427-35. LIPPINCOTT WILLIAMS & WILKINS
AIDS (London, England), 24(3), 427-435. Lippincott Williams and Wilkins
Aids, 24, 3, pp. 427-35
Contains fulltext : 88346.pdf (Publisher’s version ) (Closed access) INTRODUCTION: This study describes the characteristics of the metabolic syndrome in HIV-positive patients in the Data Collection on Adverse Events of Anti-HIV Drugs study and disc
Autor:
Adilia Warris, Julia Del amo, Roberto CAUDA, Renato Alberto Finazzi, Aba Mahamat, Antonio Chiesi, Giuseppe Ippolito, Dominique Costagliola, Margaret May, Vicente Soriano, Michael John Gill, Fiona Lampe, Maria Jose Amengual, Patrizio Pezzotti, Matthias Egger, Jonathan Sterne, Huldrych Günthard, STEFANO VELLA, Alexandra Montoliu, Willem Melchers, Adrian Streinu-Cercel, Sophie Matheron, Michael Kozal, André Cabié, Terese L Katzenstein, Annalisa Saracino, Cedric Arvieux, Bart Rijnders, Elisa De Lazzari, Alicja Wiercińska-Drapało, Carmen Cabellos, Felipe García, Mariana Gerschenson
Publikováno v:
Aids, 22, 18, pp. 2481-92
Aids, 22, 2481-92
Aids, 22(18), 2481-92. LIPPINCOTT WILLIAMS & WILKINS
AIDS (London, England), 22(18), 2481-2492. Lippincott Williams and Wilkins
Aids, 22, 2481-92
Aids, 22(18), 2481-92. LIPPINCOTT WILLIAMS & WILKINS
AIDS (London, England), 22(18), 2481-2492. Lippincott Williams and Wilkins
Contains fulltext : 70499.pdf (Publisher’s version ) (Closed access) OBJECTIVE: To determine whether differences in short-term virologic failure among commonly used antiretroviral therapy (ART) regimens translate to differences in clinical events i
Autor:
Roberto CAUDA, Renato Alberto Finazzi, Jens Lundgren, William Powderly, Antonio Chiesi, Clifford Leen, Giuseppe Ippolito, CARLO FEDERICO PERNO, Vicente Soriano, Matthew Law, Linos Vandekerckhove, Matti Ristola, Antonella D'Arminio Monforte, Terese L Katzenstein, GUIDO CAMANNI, Bart Rijnders, ANDREA COSTANTINI
Publikováno v:
Journal of the International AIDS Society
Journal of the International AIDS Society, 15(2):17426
Journal of the International AIDS Society, 15 (2
Journal of the International AIDS Society, 15(2):17426. John Wiley & Sons Inc.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
Journal of the International AIDS Society, 15(2). International AIDS Society
University of Helsinki
Petoumenos, K, Worm, S W, Fontas, E, Weber, R, De Wit, S, Bruyand, M, Reiss, P, El-Sadr, W, Monforte, A DA, Friis-Møller, N, Lundgren, J, Law, M G, D:A:D Study Group & Pedersen, C 2012, ' Predicting the short-term risk of diabetes in HIV-positive patients : the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study ', International AIDS Society. Journal, vol. 15, no. 2, pp. 17426 .
Journal of the International AIDS Society, 15(2):17426
Journal of the International AIDS Society, 15 (2
Journal of the International AIDS Society, 15(2):17426. John Wiley & Sons Inc.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
Journal of the International AIDS Society, 15(2). International AIDS Society
University of Helsinki
Petoumenos, K, Worm, S W, Fontas, E, Weber, R, De Wit, S, Bruyand, M, Reiss, P, El-Sadr, W, Monforte, A DA, Friis-Møller, N, Lundgren, J, Law, M G, D:A:D Study Group & Pedersen, C 2012, ' Predicting the short-term risk of diabetes in HIV-positive patients : the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study ', International AIDS Society. Journal, vol. 15, no. 2, pp. 17426 .
Introduction: HIV-positive patients receiving combination antiretroviral therapy (cART) frequently experience metabolic complications such as dyslipidemia and insulin resistance, as well as lipodystrophy, increasing the risk of cardiovascular disease
Autor:
Anne Johnson, Nina Friis-Moller, Renato Alberto Finazzi, Jens Lundgren, LUZ MARTÍN CARBONERO, Antonio Chiesi, Clifford Leen, Vicente Soriano, Linos Vandekerckhove, Matti Ristola, Lars Østergaard, Đorđe Jevtović, Justyna Kowalska, Thomas Benfield, Viktar M. Mitsura, Terese L Katzenstein, Vassilenko Anna
Publikováno v:
Mocroft, A, Kirk, O, Reiss, P, De Wit, S, Sedlacek, D, Beniowski, M, Gatell, J, Phillips, A N, Ledergerber, B, Lundgren, J D & EuroSIDA Study Group (Lars Østergaard, member) 2010, ' Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients ', AIDS, vol. 24, no. 11, pp. 1667-78 . https://doi.org/10.1097/QAD.0b013e328339fe53
AIDS (London, England), 24(11), 1667-1678. Lippincott Williams and Wilkins
AIDS (London, England), 24(11), 1667-1678. Lippincott Williams and Wilkins
Objectives: Chronic kidney disease (CKD) in HIV-positive persons might be caused by both HIV and traditional or non-HIV-related factors. Our objective was to investigate long-term exposure to specific antiretroviral drugs and CKD. Design: A cohort st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::028f2540f13acf43dd5344b288c4ccff
https://doi.org/10.5167/uzh-40560
https://doi.org/10.5167/uzh-40560
Autor:
Ferran Torres, Roberto CAUDA, Renato Alberto Finazzi, Jens Lundgren, Antonio Chiesi, Clifford Leen, Giuseppe Ippolito, CARLO FEDERICO PERNO, Vicente Soriano, Matthew Law, Linos Vandekerckhove, Patrizio Pezzotti, Matti Ristola, Lars Østergaard, Caroline Sabin, Terese L Katzenstein, Bart Rijnders, ANDREA COSTANTINI
Publikováno v:
European Journal of Cardiovascular Prevention and Rehabilitation, 17, 491-501
European Journal of Cardiovascular Prevention and Rehabilitation, 17, 5, pp. 491-501
European journal of cardiovascular prevention and rehabilitation, 17(5), 491-501. SAGE Publications Inc.
European journal of cardiovascular prevention & rehabilitation, 17(5), 491-501. LIPPINCOTT WILLIAMS & WILKINS
Friis-Møller, N, Thiébaut, R, Reiss, P, Weber, R, Monforte, A DA, De Wit, S, El-Sadr, W, Fontas, E, Worm, S, Kirk, O, Phillips, A, Sabin, C A, Lundgren, J D, Law, M G & DAD study group (Lars Østergaard, member) 2010, ' Predicting the risk of cardiovascular disease in HIV-infected patients : the data collection on adverse effects of anti-HIV drugs study ', European Journal of Preventive Cardiology, vol. 17, no. 5, pp. 491-501 . https://doi.org/10.1097/HJR.0b013e328336a150
European Journal of Cardiovascular Prevention and Rehabilitation, 17(5), 491-501
European Journal of Cardiovascular Prevention and Rehabilitation, 17, 5, pp. 491-501
European journal of cardiovascular prevention and rehabilitation, 17(5), 491-501. SAGE Publications Inc.
European journal of cardiovascular prevention & rehabilitation, 17(5), 491-501. LIPPINCOTT WILLIAMS & WILKINS
Friis-Møller, N, Thiébaut, R, Reiss, P, Weber, R, Monforte, A DA, De Wit, S, El-Sadr, W, Fontas, E, Worm, S, Kirk, O, Phillips, A, Sabin, C A, Lundgren, J D, Law, M G & DAD study group (Lars Østergaard, member) 2010, ' Predicting the risk of cardiovascular disease in HIV-infected patients : the data collection on adverse effects of anti-HIV drugs study ', European Journal of Preventive Cardiology, vol. 17, no. 5, pp. 491-501 . https://doi.org/10.1097/HJR.0b013e328336a150
European Journal of Cardiovascular Prevention and Rehabilitation, 17(5), 491-501
Contains fulltext : 89693.pdf (Publisher’s version ) (Closed access) AIMS: HIV-infected patients receiving combination antiretroviral therapy may experience metabolic complications, potentially increasing their risk of cardiovascular diseases (CVDs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0114defbdca88ff15b5424596be4d082
Autor:
Adriano LAZZARIN, MASSIMO GALLI, Nina Friis-Moller, Renato Alberto Finazzi, Jens Lundgren, Dalibor Sedlacek, Antonio Chiesi, Matti Ristola, Lars Østergaard, Thomas Benfield, Viktar M. Mitsura, Terese L Katzenstein, Vassilenko Anna, Alicja Wiercińska-Drapało, Miriam Lichtner
Publikováno v:
Mocroft, A, Kirk, O, Aldins, P, Chies, A, Blaxhult, A, Chentsova, N, Vetter, N, Dabis, F, Gatell, J, Lundgren, J D & EuroSIDA Study Group (Lars Østergaard, member) 2008, ' Loss to follow-up in an international, multicentre observational study ', HIV Medicine, vol. 9, no. 5, pp. 261-9 . https://doi.org/10.1111/j.1468-1293.2008.00557.x
HIV medicine, 9(5), 261-269. Wiley-Blackwell
HIV medicine, 9(5), 261-269. Wiley-Blackwell
OBJECTIVE: The aim of this work was to assess loss to follow-up (LTFU) in EuroSIDA, an international multicentre observational cohort study.METHODS: LTFU was defined as no follow-up visit, CD4 cell count measurement or viral load measurement after 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f91cf326bd780cc45ab4d044401b54e3
https://pure.au.dk/portal/da/publications/loss-to-followup-in-an-international-multicentre-observational-study(8d0daab2-2a24-4c7f-b202-850f24e30195).html
https://pure.au.dk/portal/da/publications/loss-to-followup-in-an-international-multicentre-observational-study(8d0daab2-2a24-4c7f-b202-850f24e30195).html
Autor:
Nina Friis-Moller, Renato Alberto Finazzi, Jens Lundgren, Zabrina Brumme, Antonio Chiesi, Clifford Leen, Vicente Soriano, Linos Vandekerckhove, Michael John Gill, Valerie Delpech, Matti Ristola, Lars Østergaard, Caroline Sabin, Terese L Katzenstein, Bart Rijnders, Andri Rauch, Philippa Easterbrook
Publikováno v:
University of Helsinki
Aids, 23(13), 1689-99. LIPPINCOTT WILLIAMS & WILKINS
Kesselring, A M, Wit, F W, Sabin, C A, Lundgren, J D, Gill, M J, Gatell, J M, Rauch, A, Montaner, J S, de Wolf, F, Reiss, P, Mocroft, A & Nevirapine Toxicity Multicohort Collaboration (Lars Østergaard, member) 2009, ' Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy ', AIDS, vol. 23, no. 13, pp. 1689-99 . https://doi.org/10.1097/QAD.0b013e32832d3b54
Aids, 23, 13, pp. 1689-99
AIDS (London, England), 23(13), 1689-1699. Lippincott Williams and Wilkins
Aids, 23, 1689-99
Aids, 23(13), 1689-99. LIPPINCOTT WILLIAMS & WILKINS
Kesselring, A M, Wit, F W, Sabin, C A, Lundgren, J D, Gill, M J, Gatell, J M, Rauch, A, Montaner, J S, de Wolf, F, Reiss, P, Mocroft, A & Nevirapine Toxicity Multicohort Collaboration (Lars Østergaard, member) 2009, ' Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy ', AIDS, vol. 23, no. 13, pp. 1689-99 . https://doi.org/10.1097/QAD.0b013e32832d3b54
Aids, 23, 13, pp. 1689-99
AIDS (London, England), 23(13), 1689-1699. Lippincott Williams and Wilkins
Aids, 23, 1689-99
Contains fulltext : 81637.pdf (Publisher’s version ) (Closed access) BACKGROUND: This collaboration of seven observational clinical cohorts investigated risk factors for treatment-limiting toxicities in both antiretroviral-naive and experienced pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eef023b108d0c1b72c283d7a4a5398c2
https://researchportal.helsinki.fi/en/publications/36452e5b-6792-45f9-a7c5-50bce3ba8ebe
https://researchportal.helsinki.fi/en/publications/36452e5b-6792-45f9-a7c5-50bce3ba8ebe